RECOVERY · Injectable
TB-500 + BPC-157 Combo.
The Wolverine Stack — complete healing protocol
How it works
Class & mechanism.
Class
Synthetic Peptide Stack
Mechanism
BPC-157 and TB-500 operate through distinct but convergent repair pathways, making their combination mechanistically complementary rather than redundant. BPC-157 drives angiogenesis via VEGFR2/FAK-paxillin signalling, upregulates growth hormone receptor expression in fibroblasts, and stabilises the nitric oxide system for vascular protection. TB-500 works upstream through actin sequestration, mobilising stem and progenitor cells to injury sites and upregulating TGF-β and FGF-2. Together, BPC-157 handles the vascular infrastructure (new blood supply to injured tissue) while TB-500 handles cellular logistics (recruiting the right cells to the right place). The combination addresses two of the three core bottlenecks in tissue repair simultaneously: blood supply and cell migration.
Did you know
The combination is nicknamed the 'Wolverine Stack' in biohacker and athletic communities — named after Marvel's famously self-healing mutant — because the two peptides together cover so many independent repair pathways that users describe injury timelines that seem implausibly fast compared to conventional recovery.
Benefits
What it does.
Synergistic tissue repair across multiple injury types — the complementary pathways mean the stack outperforms either peptide alone for complex musculoskeletal injuries (tendons, ligaments, muscle, bone)
Faster return to function post-surgery — addresses both the vascular repair phase (BPC-157) and the cellular remodelling phase (TB-500) in parallel rather than sequentially
Gut health and systemic healing combined — BPC-157 brings strong gastrointestinal and mucosal repair activity that TB-500 lacks, making the combo useful for athletes with gut compromise alongside physical injuries
Broad anti-inflammatory coverage — both peptides modulate inflammation through different mechanisms, reducing the risk of one pathway being insufficient for complex or chronic inflammatory states
Neurological and cardiovascular support — BPC-157's neuroprotective and gut-brain axis activity combines with TB-500's cardiac repair potential for comprehensive systemic recovery in post-surgical or high-stress contexts
The science
Peer-reviewed findings.
Research supporting this compound's mechanisms and safety profile.
Both BPC-157 and TB-500 demonstrate convergent effects on angiogenesis promotion and inflammatory modulation while maintaining distinct molecular targets — a preclinical rationale for synergistic therapeutic applications in regenerative medicine contexts
SOURCE · GlobalRPh Clinical Review: BPC-157 and TB-500 Background, Indications, Efficacy, and Safety (2025)
BPC-157 shows stronger activity in gastrointestinal and connective tissue repair models, while Thymosin Beta-4 (TB-500's parent compound) demonstrates distinct cardiac and immunological effects — the stack covers tissue types that neither covers alone
SOURCE · Newtropin.com Comparative Clinical Overview; Raw Amino comparative research review
The 'Wolverine Stack' (BPC-157 + TB-500) has generated significant interest in regenerative medicine specifically because of its biologically complementary rationale: BPC-157 targets the extracellular matrix and vascular signalling while TB-500 targets intracellular actin dynamics and cell mobilisation — two non-overlapping mechanisms
SOURCE · Medical Spa Rx: The Wolverine Stack Explained (2024)
Protocol
How to use it.
Dosing
BPC-157: 250–500 mcg daily via subcutaneous injection. TB-500: 2–4 mg twice weekly during the loading phase. Both are administered separately (never combined in the same vial — stability concerns). Typical protocol: inject BPC-157 daily near injury site; inject TB-500 2–3x weekly subcutaneously into abdomen or near injury. Total weekly TB-500 load is typically 4–6 mg during the first 4–6 weeks.
Cycle
Loading phase: 4–6 weeks at full dose (both peptides). Maintenance phase: reduce TB-500 to 2 mg/week, continue BPC-157 at 250 mcg/day for a further 4–8 weeks. Rest period of 4–8 weeks between cycles. For acute post-surgical recovery, a single 8–12 week combined cycle is common clinical practice.
Contraindications
When to skip it.
Neither peptide is FDA-approved for human therapeutic use. Both are banned by WADA. Never combine in the same syringe or vial. Theoretical cancer risk applies to both (angiogenesis promotion) — mandatory cancer screening before initiating. Use under physician supervision only. Not for use during active cancer treatment.
Always cleared with your concierge before protocol start.
Pricing
What it costs.
Indicative range for TB-500 + BPC-157 Combo, sourced from vetted US and EU dispensing suppliers. Concierge confirms the exact figure once your match is locked.
Indicative range (USD)
Sourced through vetted dispensing partners in the United States and European Union. Concierge confirms the exact figure once your match is locked.
- 0199% purity verified, third-party tested
- 02Includes vial and reconstitution guidance
- 03Concierge supplier match included with every protocol
See TB-500 + BPC-157 Combo pricing — and your supplier match.
Pricing is unlocked once we know who you are. Take the 3-minute quiz and we'll match you to a US or EU dispensary based on your location and protocol fit.
- Live USD price range
- US & EU supplier shortlist
- Concierge sign-off on dosing
Indicative price range: $136–$204 USD